Venous ThromboembolismLearning Objectives
At the completion of this activity, participants should be better able to
- Describe the risk factors for venous thromboembolism in the patient with colorectal cancer (CRC)
- List three agents commonly administered to patients with CRC that may contribute to hypercoagulability
- Define the role of low molecular weight heparin in the treatment of venous thromboembolism in patients with CRC
Provided by Meniscus Educational Institute 
and Meniscus Limited 
Supported by an educational grant from Lilly USA, LLC. 
No comments:
Post a Comment